Article
A common CD55 rs2564978 variant is associated with the susceptibility of non-small cell lung cancer.
Oncotarget - 24 Jan 2017
Zhang Yanyan, Zhang Zhi, Cao Lei, Lin Jia, Yang Zhenbang, Zhang Xuemei
Abstract excerpt
CD55, as one of key membrane-bound complement-regulatory proteins (mCRPs), is crucial for the progression of various cancers. This study aims to investigate the role of CD55 variants in the development of non-small cell lung cancer (NSCLC). A case-control study, including 706 lung cancer cases and 706 health controls, was conducted in a Chinese population. The odds ratio (OR) and 95% confidence interval (95% CI)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
